Cargando…

Treatment adherence and social functioning in patients diagnosed with schizophrenia and treated with antipsychotic depot medication

BACKGROUND AND AIM: Some of the most significant problems encountered in the treatment of schizophrenia are non-adherence to the treatment with oral neuroleptics and difficult recovery of social functioning, after its impairment by negative psychotic symptoms and the progression of the disease with...

Descripción completa

Detalles Bibliográficos
Autores principales:	POPP, BIANCA-STEPHANIE, MANEA, MARINELA MINODORA, MORARU, MADALINA OANA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iuliu Hatieganu University of Medicine and Pharmacy 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462419/ https://www.ncbi.nlm.nih.gov/pubmed/26528009 http://dx.doi.org/10.15386/cjmed-292

Ejemplares similares

Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital
por: Espiridion, Eduardo D, et al.
Publicado: (2018)

Adherence to Antipsychotic Medication and Quality of Life in Latin-American Patients Diagnosed with Schizophrenia
por: Caqueo-Urízar, Alejandra, et al.
Publicado: (2020)

A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication
por: Andor, Minodora, et al.
Publicado: (2019)

The Therapeutic Relationship and Adherence to Antipsychotic Medication in Schizophrenia
por: McCabe, Rosemarie, et al.
Publicado: (2012)

Impairment of the cardiac ejection fraction by blocking dopamine D2 receptors induced by long-acting injectable antipsychotic treatment
por: Dehelean, Liana, et al.
Publicado: (2021)

Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia
por: MacEwan, Joanna P., et al.
Publicado: (2016)

Therapeutic Particularities with Depot Medications in Schizophrenia
por: SÂRBU, C., et al.
Publicado: (2018)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial
por: Priebe, Stefan, et al.
Publicado: (2016)

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia
por: Peng, Xiaomei, et al.
Publicado: (2011)

Treatment patterns and clinical characteristics prior to initiating depot typical antipsychotics for nonadherent schizophrenia patients
por: Ascher-Svanum, Haya, et al.
Publicado: (2009)

Physical health monitoring in antipsychotic depot clinic
por: Davies, Rebecca, et al.
Publicado: (2021)

Metabolic Syndrome Monitoring in Patients on Depot Antipsychotics
por: Ateem, Salah
Publicado: (2023)

Non-adherence to antipsychotic medication, relapse and rehospitalisation in recent-onset schizophrenia
por: Morken, Gunnar, et al.
Publicado: (2008)

Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
por: Tareke, Minale, et al.
Publicado: (2018)

Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial
por: Henderson, Catherine, et al.
Publicado: (2015)

Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India
por: Raghavan, Vijaya, et al.
Publicado: (2020)

Depot Typical Antipsychotics versus Oral Atypical Antipsychotics in Relapse Rate Among Patients with Schizophrenia: A Five -Year Historical Cohort Study
por: Ahmadkhaniha, Hamid-Reza, et al.
Publicado: (2014)

Paliperidone palmitate in non-acute patients with schizophrenia previously unsuccessfully treated with risperidone long-acting therapy or frequently used conventional depot antipsychotics
por: Schreiner, A, et al.
Publicado: (2015)

Review of depot aripiprazole for schizophrenia
por: Motiwala, Farha Bilal, et al.
Publicado: (2013)

Prevalence of metabolic syndrome in schizophrenia patients treated with antipsychotic medications
por: Jaberi, Nayyer, et al.
Publicado: (2020)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Ren, Xinhua S, et al.
Publicado: (2009)

Influence of Antipsychotic Agents on the Sexuality of Patients Diagnosed with Schizophrenia
por: Fares, Jaballah, et al.
Publicado: (2023)

Risperidone long-acting injection in Schizophrenia Spectrum Illnesses compared to first generation depot antipsychotics in an outpatient setting in Canada
por: Lammers, Laura, et al.
Publicado: (2013)

Side-Effect Monitoring for Patients on Depot Antipsychotic Medication Within a Community Treatment Team
por: Waterman, Harry, et al.
Publicado: (2023)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia
por: Lertxundi, Unax, et al.
Publicado: (2018)

Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
por: Kaplan, Gabriel, et al.
Publicado: (2013)

Use of Conventional Antipsychotics and the Cost of Treating Schizophrenia
por: Lyu, Ramon R., et al.
Publicado: (2001)

F75. MEDICATION ADHERENCE AND DISCONTINUATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH ARIPIPRAZOLE ONCE-MONTHLY LONG-ACTING INJECTABLE VERSUS THOSE TREATED WITH ORAL ANTIPSYCHOTICS
por: Greene, Mallik, et al.
Publicado: (2018)

Improving Cardiac Monitoring for Patients on Depot Antipsychotic Medication in a Mental Health Service for Homeless People
por: Hall, Hugh, et al.
Publicado: (2023)

The link between personality dimensions and pain perception in patients with diabetes mellitus or cancer
por: Petraşcu, Cătălina-Maria, et al.
Publicado: (2019)

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia
por: Ascher-Svanum, Haya, et al.
Publicado: (2008)

Influence of an inconsistent appearance of antipsychotics on drug adherence in patients with schizophrenia: Erratum
Publicado: (2018)

Adherence to oral second-generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claims
por: Stephenson, J J, et al.
Publicado: (2012)

Economic burden in Medicaid beneficiaries with recently relapsed schizophrenia or with uncontrolled symptoms of schizophrenia not adherent to antipsychotics
por: Pilon, Dominic, et al.
Publicado: (2021)

Predictors of switching antipsychotic medications in the treatment of schizophrenia
por: Nyhuis, Allen W, et al.
Publicado: (2010)

Language disturbances in schizophrenia: the relation with antipsychotic medication
por: de Boer, J. N., et al.
Publicado: (2020)

Antipsychotic medication for women with schizophrenia spectrum disorders
por: Brand, Bodyl A., et al.
Publicado: (2022)

Antipsychotic polypharmacy in adult patients diagnosed with schizophrenia: A retrospective study
por: Patrichi, Bogdan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_57209amaaubpboj93or0qpo24b